You are here: Industry Insights > acquisition

News List

Pharmaceutical Business Progress in China and Worldwide (March) PharmaSources
May 12, 2023
Progress in Pharmaceutical Business at Home and Abroad (March)
A Look at 2021 Mergers and Acquisitions SHEM OIRERE
December 17, 2021
The COVID-19 health crisis has introduced new dynamics in the global healthcare system while pushing leading pharmaceutical companies into investing more in research and development as others are enticed into mergers...
Mérieux NutriSciences Completes Acquisition of Bureau Veritas' Food Testing Activities in Japan, Morocco, Southeast Asia, and South Africa PharmaSources
February 04, 2025
Mérieux NutriSciences acquires Bureau Veritas' food testing activities in multiple regions, strengthening its global presence in food testing.
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform PRNewswire
January 31, 2025
Telix completes the acquisition from ImaginAb, getting a drug pipeline and a biologics technology platform.
Novotech Acquires US-based Drug Development Consulting Firm, CBR International PharmaSources
January 12, 2023
Expands Drug Development and FDA Regulatory Expertise
Novotech Acquires European CRO, Strengthens Global Operations PharmaSources
January 12, 2023
The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
Sanofi completes acquisition of Amunix WorldPharmaNews
February 10, 2022
Sanofi announced the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine therapies. The acquisition also provides access to Amunix Pro-XTEN...
CSL to acquire Switzerland’s Vifor Pharma for $11.7bn Pharmaceutical-Technology
December 16, 2021
CSL has signed a definitive agreement for the acquisition of all publicly held stakes of Switzerland-based Vifor Pharma in a deal worth $11.7bn (A$16.4bn) in cash.
Pfizer signs agreement to acquire Arena Pharmaceuticals for $6.7bn Pharmaceutical-Technology
December 15, 2021
Pfizer has signed a definitive agreement for the acquisition of all the outstanding shares of clinical-stage firm Arena Pharmaceuticals in a deal worth nearly $6.7bn or $100 for each share in cash.
Vaxart Announces Acquisition of Second GMP Manufacturing Facility AmericanPharmaceuticalReview
December 02, 2021
Vaxart, Inc. has entered into an agreement with Kindred Bioscience, Inc. for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing facility in Burlingame, California, giving Vaxart...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page